3 completed, 2 terminated. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 2 |
| Phase 2 | 1 | Completed 1 |
Follow Lupus Erythematosus, Discoid: new trials by email Literature Review of Lupus Erythematosus, Discoid trials Research Report on Lupus Erythematosus, Discoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus BMS-986326, Placebo for BMS-986326 - Lupus | Phase 1 | Completed | Bristol-Myers Squibb | 45 | 2023-09-21 | 2026-05-26 |
| Autologous Polyclonal Tregs for Lupus Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells - Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid | Phase 1 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 1 | 2015-08-27 | 2019-11-12 |
| Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus AMG811, AMG811 Placebo - Cutaneous Lupus, Discoid Lupus | Phase 1 | Terminated | Amgen | 16 | 2010-08-01 | 2014-09-16 |
| Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients CC-10004 - Discoid Lupus Erythematosus | Phase 1 / Phase 2 | Completed | NYU Langone Health | 8 | 2008-06-01 | 2021-03-03 |
| Phase Ib Study of SC Milatuzumab in SLE milatuzumab, Placebo - Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid | Phase 1 | Completed | Gilead Sciences | 22 | 2007-01-01 | 2021-08-19 |
Lupus Erythematosus, Systemic (4) · Lupus Erythematosus, Cutaneous (3) · Lupus Nephritis (1) · Lupus Vasculitis, Central Nervous System (1)
Connective Tissue Diseases (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Autoimmune Diseases (4) · Immune System Diseases (4) · Lupus Erythematosus, Cutaneous (2) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Central Nervous System Viral Diseases (1) · Cerebrovascular Disorders (1) · Encephalitis (1) · Female Urogenital Diseases (1)
apremilast (1) · milatuzumab (1)
Amgen (1) · Bristol-Myers Squibb (1) · Gilead Sciences (1) · NYU Langone Health (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (5) · Argentina (1) · Bulgaria (1) · Germany (1) · Netherlands (1) · Poland (1) · Romania (1) · Spain (1)
Andrew G Franks, Jr., MD (1) · Anna Haemel, MD (1) · David Wofsy, MD (1) · Jeffrey Bluestone, PhD (1) · Maria Dall'Era, MD (1) · Michael Rosenblum, MD, PhD (1) · William Wegener, PhD, MD (1)